Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024 VANCOUVER, British Columbia, May 08, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced that the company will present at the BofA Securities Health Care Conference 2024 taking place May 14-16, 2024 in Las Vegas, NV. Fireside Chat Presentation Details:Date:Wednesday, May 15, 2024Time:3:40 pm Pacific Time (6:40 pm Eastern Time)Webcast:Presenters:Ian Mortimer, President and Chief Executive OfficerSherry Aulin, Chief Financial Of...
NETSOL Technologies Reschedules Fiscal Third Quarter 2024 Conference Call ENCINO, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- NETSOL Technologies, Inc. (Nasdaq: NTWK), a global business services and enterprise application solutions provider, today announced that it will postpone the release of its financial results and conference call related to the fiscal third quarter of 2024 ended March 31, 2024, which had previously been scheduled for Thursday, May 9. The Company now expects to hold a conference call on Monday, May 20, at 9:00 a.m. Eastern Time (6:00 a.m. Pacific Time) to discuss its fin...
STRATA Skin Sciences to Report First Quarter 2024 Financial Results on May 15, 2024 and Provide Corporate Update HORSHAM, Penn., May 08, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that it will report first quarter 2024 financial results on Wednesday, May 15, 2024 after the market close. STRATA management will host a conference call at 4:30 p.m. ET on Wednesday, May 15, 2024 to...
Capital Southwest expands Executive Team with Key Promotions DALLAS, May 07, 2024 (GLOBE NEWSWIRE) -- Capital Southwest Corporation (“Capital Southwest”) (Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, announced today that its Board of Directors has approved the promotion of Josh Weinstein to Senior Managing Director and Chief Investment Officer and Chris Rehberger to Executive Vice President and Treasurer, effective immediately. Bowen Diehl, Capital Sou...
Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference VANCOUVER, British Columbia, May 07, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced that the company will present at the 2024 RBC Capital Markets Global Healthcare Conference taking place May 14-15, 2024 in New York, NY. Fireside Chat Presentation Details: Date:Tuesday, May 14, 2024Time:3:35 pm Eastern TimeWebcast:Presenters:Ian Mortimer, President and Chief Executive OfficerSherry Aulin, Chief Financial Of...
A director at Green Brick Partners Inc sold 40,000 shares at 56.770USD and the significance rating of the trade was 81/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update VANCOUVER, British Columbia, May 02, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced it will report its first quarter 2024 financial and operating results after the close of U.S. financial markets on Thursday, May 9, 2024. Conference Call/Webcast Information: Date:Thursday, May 9, 2024 Time:4:30 pm Eastern Time (1:30 pm Pacific Time) Webcast: Dial-In: (800) 715-9871 ...
XBP Europe Awarded a Transformation Project for His Majesty’s Passport Office (HMPO) LONDON, May 02, 2024 (GLOBE NEWSWIRE) -- XBP Europe (“XBP Europe” or the “Company”) (NASDAQ: XBP and XBPEW), today announced that the Company has been selected by His Majesty’s Passport Office (“HMPO”) as its technology and services partner on a nationwide project, which aims to make documents dating back to 1837 digitally available to the General Register Office (“GRO”). This multi-year contract in the UK has an approximate total contract value of $40 million. A duty to the publicThe GRO, part of HMPO, ...
XBP Europe Awarded a Transformation Project for His Majesty’s Passport Office (HMPO) NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- XBP Europe (“XBP Europe” or the “Company”) (NASDAQ: XBP and XBPEW), today announced that the Company has been selected by His Majesty’s Passport Office (“HMPO”) as its technology and services partner on a nationwide project, which aims to make documents dating back to 1837 digitally available to the General Register Office (“GRO”). This multi-year contract in the UK has an approximate total contract value of $40 million. A duty to the publicThe GRO, part of HMPO...
ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024 Conference Call Scheduled for May 9, 2024, at 4:30 p.m. ET RAMSEY, N.J. and BOCA RATON, Fla., May 02, 2024 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, today announced that it will report first quarter 2024 financial results on May 9, 2024, after the U.S. financial markets close. ADMA’s management team will host a live conference call and audio webca...
DALLAS--(BUSINESS WIRE)-- Sunoco LP (NYSE: SUN) (“Sunoco” or “SUN”) and NuStar Energy L.P. (NYSE: NS) (“NuStar” or “NS”) announced the approval by NuStar unitholders of the previously announced merger, pursuant to which NuStar will merge with and into a merger subsidiary of Sunoco. This press release features multimedia. View the full release here: NuStar’s Special Meeting was held at 9:00 a.m. Central Time on May 1, 2024. According to preliminary results of the Special Meeting, approximately 69% of the outstanding common units of NuStar voted in favor of the transaction. NuStar will disclos...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.